Evidence map›Paper›PMID 34564712›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT

Harrison M Fontaine, Phillip R Silva, Carlie Neiswanger, Rachelle Tran, Antony D Abraham, Benjamin B Land, John F Neumaier, Charles Chavkin

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Harrison M FontaineDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Phillip R SilvaCenter for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Carlie NeiswangerDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Rachelle TranDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Antony D AbrahamDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Benjamin B LandDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
John F NeumaierDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0002-1763-7118
Charles ChavkinDepartment of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA. cchavkin@uw.edu.ORCID http://orcid.org/0000-0001-8048-476X
University of Washington · US

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0M
Pharmacological Sciences SupplementT32GM007750 · NIGMS · UNIVERSITY OF WASHINGTON · PI ATKINS, WILLIAM M · 1985 to 2023
$12.6M
TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGST32DA007278 · NIDA · UNIVERSITY OF WASHINGTON · PI Susan Marie Ferguson, Paul E. M. Phillips · 1993 to 2026
$9.8M
Therapeutic Potential of Kappa Antagonists in the Adjunctive Treatment of Psychotic DepressionP50MH106428 · NIMH · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2015 to 2019
$7.6M
p38 MAPK Mechanisms of Kappa Opioid-Induced BehaviorsR01DA030074 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2011 to 2020
$3.2M
Mechanisms of pathway-specific plasticity in the incubation of cravingR01DA041356 · NIDA · UNIVERSITY OF WASHINGTON · PI NEUMAIER, JOHN F · 2017 to 2021
$2.2M
NIDA NIH HHS R01 DA030074NIMH NIH HHS P50 MH106428
6 · The paper itself

Abstract

Stress-induced release of dynorphins (Dyn) activates kappa opioid receptors (KOR) in serotonergic neurons to produce dysphoria and potentiate drug reward; however, the circuit mechanisms responsible for this effect are not known. In male mice, we found that conditional deletion of KOR from Slc6a4 (SERT)-expressing neurons blocked stress-induced potentiation of cocaine conditioned place preference (CPP). Within the dorsal raphe nucleus (DRN), two overlapping populations of KOR-expressing neurons: Slc17a8 (VGluT3) and SERT, were distinguished functionally and anatomically. Optogenetic inhibition of these SERT

Indexed as

CocaineAnimalsMaleMiceMice, Inbred C57BLNucleus AccumbensReceptors, Opioid, kappaSerotoninCocaineReceptors, Opioid, kappaSerotonin

Identifiers

PMID34564712
PMCPMC8882182
OpenAlexW3204106422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.